Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-9.2%
5Y CAGR+32.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-9.2%/yr
Annual compound
5Y CAGR
+32.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
4.1x
Strong expansion
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.11M | -16.0% |
| 2024 | $23.95M | -9.6% |
| 2023 | $26.48M | -1.4% |
| 2022 | $26.84M | -3.6% |
| 2021 | $27.83M | +460.9% |
| 2020 | $4.96M | +43.2% |
| 2019 | $3.46M | - |